摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

α-conidendrin

中文名称
——
中文别名
——
英文名称
α-conidendrin
英文别名
(3aR,9aR)-7-hydroxy-9-(4-hydroxy-3-methoxyphenyl)-6-methoxy-3a,4,9,9a-tetrahydro-1H-benzo[f][2]benzofuran-3-one
α-conidendrin化学式
CAS
——
化学式
C20H20O6
mdl
——
分子量
356.375
InChiKey
CAYMSCGTKZIVTN-YCENCERGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    26
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    85.2
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    α-conidendrin三氟甲磺酸potassium carbonate 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 生成 (6aR,9aR)-4-methoxy-10-(7-methoxy-2-methylbenzofuran-5-yl)-2-methyl-6,9,9a,10-tetrahydronaphtho-[2,1-b:6,7-c']difuran-7(6aH)-one
    参考文献:
    名称:
    One-pot propargylation and Claisen-type rearrangement for natural lignans matairesinol and α-conidendrin
    摘要:
    针对天然木脂素--马黛茶苷醇和α-考来烯菊酯--设计了改进的单锅丙炔化和克莱森重排方法。重排具有区域特异性,只产生 2-甲基苯并呋喃衍生物。
    DOI:
    10.1007/s10593-020-02755-9
  • 作为产物:
    描述:
    hydroxymatairesinol对甲苯磺酸 作用下, 以 乙腈 为溶剂, 反应 0.17h, 以97%的产率得到α-conidendrin
    参考文献:
    名称:
    具有抗氧化性能和亲脂性的木质素7'-羟基苦参醇的衍生物
    摘要:
    当从C位的羟基上进行酯化反应时,从冷杉(Abies alba),云杉(Picea abies)和道格拉斯冷杉(Pseudotsuga menziesii)的the节木中提取的木脂素7'-hydroxymatairesinol(1)表现出出乎意料的反应性。 -7'。为了规避快速的分子内环化过程,定量地导致木脂分枝孢菌素(7),开发了一种在温和条件下(3步,总收率高达80%)进行1'的7 '酯化的简单策略。相比hydroxymatairesinol(1)(对数ķ '瓦特= 1.49),所述衍生物(2 -5)曾与日志增加亲脂性ķ '瓦特> 3.1,如通过UHPLC方法测定。化合物1 - 5种在相同的范围内的标准抗坏血酸和α生育酚表现出强效的抗氧化性质(IC 50 = 20-25μM),并使用DPPH自由基清除测定比BHT的更高。
    DOI:
    10.1021/acs.jnatprod.6b01124
点击查看最新优质反应信息

文献信息

  • Oxidative dehydrogenation of a biomass derived lignan – Hydroxymatairesinol over heterogeneous gold catalysts
    作者:Olga A. Simakova、Elena V. Murzina、Päivi Mäki-Arvela、Anne-Riikka Leino、Betiana C. Campo、Krisztián Kordás、Stefan M. Willför、Tapio Salmi、Dmitry Yu. Murzin
    DOI:10.1016/j.jcat.2011.05.025
    日期:2011.8
    Synthesis of the lignan oxomatairesinol via oxidative dehydrogenation of the naturally occurring lignan hydroxymatairesinol was studied over gold catalysts supported on C, TiO2, SiO2, Al2O3, and MgO. In order to investigate the reaction performance over the gold catalyst, synthesis of lignan oxomatairesinol was carried out in different organic solvents/water mixtures under synthetic air and nitrogen atmosphere at 373 K, and using also isolated hydroxymatairesinol isomers as a starting material. The results were compared with those obtained over palladium catalysts. Synthesized supported gold catalysts as well as the corresponding supports were characterized by TEM, XRD, ICP-OES, CO2-TPD, FUR (using pyridine as a probe molecule), and XPS. Gold catalysts were shown to display superior performance compared with palladium ones: the activity was 4 times higher, with selectivity toward oxomatairesinol being 100%, while 60-85% were obtained over palladium catalysts. In contrast to palladium, the activity of gold catalysts is high in aerobic conditions and water-propan-2-ol mixture. However, activity and selectivity of gold catalysts were shown to be dependent on the electronic state of the metal and, similar to palladium catalysts, on the support acidity. (C) 2011 Elsevier Inc. All rights reserved.
  • One-pot propargylation and Claisen-type rearrangement for natural lignans matairesinol and α-conidendrin
    作者:Dmitry S. Ryabukhin、Lucas Lagerquist、Patrik Runeberg、Jani Rahkila、Patrik C. Eklund
    DOI:10.1007/s10593-020-02755-9
    日期:2020.7
    Improved methods for one-pot propargylation and Claisen rearrangement have been devised for natural lignans – matairesinol and α-conidendrin. The rearrangement was regiospecific, yielding only 2-methylbenzofuran derivatives.
    针对天然木脂素--马黛茶苷醇和α-考来烯菊酯--设计了改进的单锅丙炔化和克莱森重排方法。重排具有区域特异性,只产生 2-甲基苯并呋喃衍生物。
  • Derivatives of the Lignan 7′-Hydroxymatairesinol with Antioxidant Properties and Enhanced Lipophilicity
    作者:Thomas Moraux、Stéphane Dumarçay、Philippe Gérardin、Christine Gérardin-Charbonnier
    DOI:10.1021/acs.jnatprod.6b01124
    日期:2017.6.23
    simple strategy for 7′-esterification of 1 under mild conditions (three steps, up to 80% overall yield) was developed. Compared to hydroxymatairesinol (1) (log K′w = 1.49), the derivatives (2–5) had increased lipophilicity with log K′w > 3.1, as determined by a UHPLC method. Compounds 1–5 exhibited potent antioxidant properties in the same range as the standards ascorbic acid and α-tocopherol (IC50
    当从C位的羟基上进行酯化反应时,从冷杉(Abies alba),云杉(Picea abies)和道格拉斯冷杉(Pseudotsuga menziesii)的the节木中提取的木脂素7'-hydroxymatairesinol(1)表现出出乎意料的反应性。 -7'。为了规避快速的分子内环化过程,定量地导致木脂分枝孢菌素(7),开发了一种在温和条件下(3步,总收率高达80%)进行1'的7 '酯化的简单策略。相比hydroxymatairesinol(1)(对数ķ '瓦特= 1.49),所述衍生物(2 -5)曾与日志增加亲脂性ķ '瓦特> 3.1,如通过UHPLC方法测定。化合物1 - 5种在相同的范围内的标准抗坏血酸和α生育酚表现出强效的抗氧化性质(IC 50 = 20-25μM),并使用DPPH自由基清除测定比BHT的更高。
查看更多

同类化合物

鬼臼脂毒酮 鬼臼毒素-4-O-葡萄糖苷 鬼臼毒素 鬼臼毒素 苦鬼臼毒素 脱氧鬼臼毒素 磷酸依托泊甙 盾叶鬼臼素 澳白木脂素2 澳白木脂素1 替尼泊苷 托尼依托泊苷 去氧鬼臼毒素 克立米星C 他氟泊苷 丙氨酸,N-(羧基甲基)-(9CI) alpha-盾叶鬼臼素 alpha-依托泊苷 [(5R,5aR,8aR,9R)-9-(4-羟基-3,5-二甲氧基-苯基)-8-氧代-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二氧戊环-5-基]丁酸酯 TOP-53二盐酸盐 NK-611盐酸盐 5,8,8a,9-四氢-9-羟基-5-(3,4,5-三甲氧基苯基)-(5R,5aR,8aR,9S)-呋喃并[3',4':6,7]萘并[2,3-d]-1,3-二氧杂环戊烯-6(5aH)-酮 4’-去甲鬼臼毒素 4’-去甲基表鬼臼毒素-Β-D-葡萄糖甙 4-{[(5S,5aS,8aR,9R)-9-(4-羟基-3,5-二甲氧苯基)-8-羰基-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基]氨基甲酰}苯基乙酸酯 4,6-O-苄叉-Β-D-葡萄糖甙鬼臼毒素 4'-去甲基表鬼臼毒素 4'-O-脱甲基-4-((4'-(1'-苯甲基哌啶基))氨基)-4-脱氧鬼臼毒 4 ’-去甲去氧鬼臼毒素 3-羟基-4H-吡喃-4-酮 3-氨基-N-[(5S,5aS,8aR,9R)-9-(4-羟基-3,5-二甲氧苯基)-8-羰基-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基]苯酰胺 2’-O-没食子酰基金丝桃甙 2(3H)-硫代酰苯,3-乙基二氢-3-(1-甲基乙基)-(9CI) 2'-氯依托泊苷 1-羟基-17-氧杂五环[6.6.5.0~2,7~.0~9,14~.0~15,19~]十九碳-2,4,6,9,11,13-六烯-16,18-二酮(non-preferredname) (8aR,9S)-9-[[(2R)-7,8-二羟基-2-(2-噻吩基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5S,5aS,8aR,9R)-5-[(4-氟苯基)氨基]-9-(4-羟基-3,5-二甲氧基-苯基)-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二氧戊环-8-酮 (5S,5aR,8aR,9R)-9-(4-羟基-3,5-二甲氧基-苯基)-5-(4-羟基苯基)硫烷基-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二噁唑-8-酮 (5R,5aR,8aS,9S)-9-[(4-氨基苯基)氨基]-5-(4-羟基-3,5-二甲氧苯基)-5,8,8a,9-四氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-6(5aH)-酮盐酸(1:1) (5R,5aR,8aR,9R)-9-羟基-10-甲氧基-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-9-[[(6R,7R,8R)-7,8-二羟基-2-(4-甲氧基苯基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-F][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-9-[[(6R,7R,8R)-7,8-二羟基-2-(2-羟基苯基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-F][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-8-羰基-9-(3,4,5-三甲氧苯基)-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基乙酸酯 (5R,5aR,8aR,9R)-5-(4-乙氧基-3,5-二甲氧基-苯基)-9-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-5-(3,5-二甲氧基-4-丙氧基-苯基)-9-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R)-5,8,8ab,9-四氢-5b-(3,4,5-三甲氧基苯基)呋喃并[3',4':6,7]萘并[2,3-d]-1,3-二氧杂环戊烯-6(5abH),9-二酮 (5-氯吡啶-3-基)丙酸甲酯 (3aS,4S,9R,9aR)-4-[(4-氟苯基)氨基]-9-(4-羟基-3,5-二甲氧基苯基)-6,7-二甲氧基-3a,4,9,9a-四氢-3H-萘并[3,2-c]呋喃-1-酮 (3aR,4S,9R,9aR)-4,6,7-三羟基-9-(4-羟基-3,5-二甲氧苯基)-3a,4,9,9a-四氢萘并[2,3-c]呋喃-1(3H)-酮 (1R,3aS,4R,6aR)-4-(1,3-苯并二氧戊环-4-基)-1-(1,3-苯并二氧戊环-5-基)-3,3a,4,6a-四氢-1H-呋喃并[3,4-c]呋喃-6-酮